InfuSystem Holdings (INFU) Total Non-Current Liabilities (2010 - 2019)
InfuSystem Holdings' (INFU) quarterly Total Non-Current Liabilities came in at $52.1 million in Q2 2019, up 53.89% YoY from $33.9 million in Q2 2018, and up 9.7% on a QoQ basis from $47.5 million in Q1 2019.
InfuSystem Holdings (INFU) Total Non-Current Liabilities (2010 - 2019) Analysis & Trends
InfuSystem Holdings (INFU) has 9 years of Total Non-Current Liabilities data on file, last reported at $52.1 million in Q2 2019.
- Quarterly Total Non-Current Liabilities rose 53.89% year-over-year to $52.1 million in Q2 2019, while the trailing twelve-month figure through Jun 2019 was $52.1 million (up 53.89% YoY) and the FY2018 annual result came in at $43.6 million, up 15.04% from the prior year.
- Total Non-Current Liabilities grew to $52.1 million in Q2 2019, from $47.5 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $52.1 million in Q2 2019 to a low of $2.1 million in Q1 2017.
- A 5-year average of $34.1 million and a median of $33.8 million in 2018 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2016 — Total Non-Current Liabilities decreased 1.9% — and 2018, when it soared 1471.9%.
- Tracing INFU's Total Non-Current Liabilities over 5 years: stood at $29.8 million in 2015, then fell by 1.9% to $29.2 million in 2016, then grew by 29.82% to $37.9 million in 2017, then gained by 15.04% to $43.6 million in 2018, then grew by 19.43% to $52.1 million in 2019.
- The last three Total Non-Current Liabilities figures came in at $52.1 million (Q2 2019), $47.5 million (Q1 2019), and $43.6 million (Q4 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | InfuSystem Holdings | 244.67 Mn | 243.70 Mn | 21.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 52.11 Mn |
| Mar 31, 2019 | 47.50 Mn |
| Dec 31, 2018 | 43.63 Mn |
| Sep 30, 2018 | 43.39 Mn |
| Jun 30, 2018 | 33.86 Mn |
| Mar 31, 2018 | 33.73 Mn |
| Dec 31, 2017 | 37.93 Mn |
| Sep 30, 2017 | 26.64 Mn |
| Jun 30, 2017 | 29.02 Mn |
| Mar 31, 2017 | 2.15 Mn |
| Dec 31, 2016 | 29.22 Mn |
| Dec 31, 2015 | 29.78 Mn |
| Sep 30, 2013 | 34.77 Mn |
| Jun 30, 2013 | 34.94 Mn |
| Mar 31, 2013 | 35.70 Mn |
| Dec 31, 2012 | 37.51 Mn |
| Mar 31, 2012 | 35.62 Mn |
| Dec 31, 2011 | 35.68 Mn |
| Sep 30, 2011 | 38.36 Mn |
| Jun 30, 2011 | 36.01 Mn |